A top heavyweight has been flagged by USADA.
Ben Rothwell is facing a UFC anti-doping policy violation stemming from a Feb. 6 sample collection, the UFC announced Tuesday. Rothwell likely failed a drug test, though the substance is not announced by the UFC nor USADA until the completion of the adjudication process unless the athlete divulges it first.
Rothwell, 35, was slated to face Fabricio Werdum at UFC 211 on May 13 in Dallas, but is now provisionally suspended pending the USADA investigation. It’s immediately unclear if the UFC will look for another opponent for Werdum for that card.
Rothwell (36-10) was suspended nine months by the UFC in 2013 for elevated levels of testosterone stemming from an in-competition sample collected in relation to Rothwell’s UFC 164 fight with Brandon Vera. Rothwell was a user of testosterone replacement therapy (TRT) at the time, but reportedly did not have a valid therapeutic use exemption (TUE) for that bout. He was not suspended by the Wisconsin Athletic Commission.
The previous failed drug test can be taken into account by USADA during its adjudication process to determine sanction length.
Rothwell, a Wisconsin native, was on a four-fight winning streak before falling via unanimous decision to Junior dos Santos in April 2016. Rothwell was supposed to meet Werdum last September, but withdrew due to injury.
Source:: mma fighting